Pancreatic Cancer Research

ResearcherRutgers New Jersey Medical SchoolActive in the last 2 years

Simran Arjani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3269-648X; OpenAlex author ID A5002497112. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 2 papers · 2023: 2 papers · 2024: 1 paper

Papers 5

  1. Cost-effectiveness of staging laparoscopy with peritoneal cytology in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.cpsurg.2024.101442↗
  2. Autoimmune conditions and pancreatic cancer risk in older American adults. Co-author DOI 10.1002/ijc.34235↗
  3. Neoadjuvant Treatment Versus Upfront Surgery in Resectable Pancreatic Cancer: A Cost-Effectiveness Analysis. Co-author DOI 10.1200/op.22.00536↗
  4. Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk. Co-author DOI 10.1093/jncics/pkac066↗
  5. Staging CT and Diagnostic Laparoscopy With Cytology Prior to the Treatment of Pancreatic Adenocarcinoma: A Case Series. Co-author DOI 10.7759/cureus.31883↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ravi J. Chokshi · 3 shared papers, 2022–2024 · strength 0.66
  2. Neal S. Panse · 2 shared papers, 2022–2024 · strength 0.44
  3. Sachelly Julián‐Serrano · 2 shared papers, 2022–2023 · strength 0.41
  4. Rachael Z. Stolzenberg‐Solomon · 2 shared papers, 2022–2023 · strength 0.41
  5. Maya Jodidio · 1 shared paper, 2024 · strength 0.26
  6. Fangcheng Yuan · 1 shared paper, 2023 · strength 0.20
  7. Guido Eibl · 1 shared paper, 2022 · strength 0.20
  8. Patrick L. Quinn · 1 shared paper, 2022 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.